Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbott, Ancora Heart, H.U. Group Holdings, Fujirebio Holdings, Fujirebio Diagnostics, Pharmasens, Sibionics, Tandem Diabetes, Thermo Fisher.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bayer, Bio-Thera, Cel-Sci, Cycle, Eisai, Eli Lilly, Excellthera, Exelixis, Gilead, GSK, Incyte, Ipsen, Johnson & Johnson, Madrigal, Merck, Orion, Regeneron, Relief, Sanofi, Springworks.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abtherx, GPCR, Indivior, Neurocrine, Prothena.